Medco Health Solutions (MHS) Tops Q2 EPS by 2c; Revs Little Light
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MHS Hot Sheet
Price: $70.30 --0%
Financial Fact:
Interest (income) and other (income) expense, net: -300K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Interest (income) and other (income) expense, net: -300K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Medco Health Solutions, Inc. (NYSE: MHS) reported Q2 EPS of $0.96, $0.02 better than the analyst estimate of $0.94. Revenue for the quarter came in at $17.07 billion versus the consensus estimate of $17.08 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Booz Allen Hamilton (BAH) Tops Q2 EPS by 28c, Misses on Revenue
- Gorman-Rupp (GRC) Tops Q3 EPS by 16c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
